Human Microbiome Market Analysis by Product (Prebiotics, Drugs, Diagnostic Tests, Probiotics), by Disease (Infectious Diseases, Gastrointestinal Diseases, Endocrine & Metabolic Disorders, Cancer), by Application (Therapeutic, Diagnostic), by Technology, and by Region - Forecast to 2029

Request Sample Page

The global human microbiome market size is estimated to be USD xx billion in 2021 and is expected to witness a CAGR of xx% during the forecast period. Growing emphasis on development of human microbiome therapeutics is a key driver for the growth of the global human microbiome market. Additionally, human microbiome as an authenticated target for drug development and growth in human microbiome-based tests for prompt detection & diagnosis are some of the other drivers propelling the market growth. Nevertheless, stringent government regulations related to new product launches and lack of knowledge and insufficient research are expected to restrain the global market growth.

Global Human Microbiome Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Product

Based on product, the market is segmented into prebiotics, drugs, diagnostic tests, probiotics, and other products. In 2021, the probiotics segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to growing health concerns and rising awareness concerning the relation of nutrition and diet worldwide. Prebiotics segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the growing number new product launches in the developing markets.

By Disease

Based on disease, the market is segmented into infectious diseases, gastrointestinal diseases, endocrine & metabolic disorders, cancer, and other diseases. In 2021, the infectious diseases segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to rise in cases of infections due to microbial dysbiosis worldwide. Cancer segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the growing number of clinical trials that are used for the development of target-specific microbiome-based therapies.

By Application

Based on application, the market is categorized into therapeutic applications and diagnostic applications. In 2021, the therapeutic applications segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the growth in funding for R&D keen on microbiome-based therapies worldwide. The diagnostic applications segment is anticipated to grow at a profitable CAGR during the forecast period, due the technological developments and the growing number of clinical trials.

By Technology

Based on technology, the market is categorized into proteomics, genomics, and metabolomics. In 2021, the genomics segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the growing number of ventures funded by private and government organisations worldwide. The proteomics segment is anticipated to grow at a profitable CAGR during the forecast period, due the high rate of penetration of proteomics in developed regions.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the increase in cases of lifestyle diseases, growing awareness on preventive healthcare, and accessibility of funding for microbiome research in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the growing number of microbiome research & clinical activities, growing government and corporate investment in healthcare sector, and availability of raw material at economic costs, are the major factors in this region.

Competitor Insights

Some of the key players in the human microbiome market are ENTEROME Bioscience (France); Seres Therapeutics. (U.S.); 4D pharma (U.K.); Evelo Biosciences (U.S.); OptiBiotix Health (U.K.); Synlogic (U.S.); Second Genome (U.S.); Vedanta Biosciences (U.S.); Ferring Pharmaceuticals (Switzerland); and ViThera Pharmaceuticals (U.S.). The leading players operating in the human microbiome industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The human microbiome market report is categorized into the following segments and subsegments:

Human Microbiome Market, By Product (Revenue, USD Billion, 2021 – 2029)

  • Prebiotics
  • Drugs
  • Diagnostic Tests
  • Probiotics
  • Other Products

Human Microbiome Market, By Disease (Revenue, USD Billion, 2021 – 2029)

  • Infectious Diseases
  • Gastrointestinal Diseases
  • Endocrine & Metabolic Disorders
  • Cancer
  • Other Diseases

Human Microbiome Market, By Application (Revenue, USD Billion, 2021 – 2029)

  • Therapeutic Applications
  • Diagnostic Applications

Human Microbiome Market, By Technology (Revenue, USD Billion, 2021 – 2029)

  • Proteomics
  • Genomics
    • Sequencing
      • 16S rRNA Sequencing Method
      • Whole-Genome Sequencing(WGS)Method
      • Other Sequencing Methods
    • Other Genomic Technologies
  • Metabolomics

Human Microbiome Market, By Region (Revenue, USD Billion, 2021 – 2029)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Human Microbiome Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Human Microbiome Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction:Human Microbiome
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis:Human Microbiome Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Product
    1. Prebiotics
      1. Prebiotics Market Forecast, 2021-2029 (USD Million)
    2. Probiotics
      1. Probiotics Market Forecast, 2021-2029 (USD Million)
    3. Drugs
      1. Drugs Market Forecast, 2021-2029 (USD Million)
    4. Diagnostic tests
      1. Diagnostic tests Market Forecast, 2021-2029 (USD Million)
    5. Other products
      1. Other products Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Application
    1. Diagnostics
      1. Diagnostics Market Forecast, 2021-2029 (USD Million)
    2. Therapeutics
      1. Therapeutics Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Disease
    1. Gastrointestinal disease
      1. Gastrointestinal disease Market Forecast, 2021-2029 (USD Million)
    2. Infectious disease
      1. Infectious disease Market Forecast, 2021-2029 (USD Million)
    3. Cancer
      1. Cancer Market Forecast, 2021-2029 (USD Million)
    4. Endocrine and metabolic disorders
      1. Endocrine and metabolic disorders Market Forecast, 2021-2029 (USD Million)
    5. Other diseases
      1. Other diseases Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Research technology
    1. Proteomics
      1. Proteomics Market Forecast, 2021-2029 (USD Million)
    2. Metabolomics
      1. Metabolomics Market Forecast, 2021-2029 (USD Million)
    3. Hospitals & trauma centers
      1. Genomics Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Human Microbiome Market
    1. North America Human Microbiome Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
        4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
      2. S. Human Microbiome Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
          4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
        2. Canada Human Microbiome Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
            4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
  1. Europe Human Microbiome Market
    1. Europe Human Microbiome Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
        4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
      2. Germany Human Microbiome Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
          4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
        2. UK Human Microbiome Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
            4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
          2. France Human Microbiome Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
              4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
            2. Spain Human Microbiome Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
                4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
              2. Italy Human Microbiome Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                  3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
                  4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
                2. Rest of EuropeHuman Microbiome Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                    3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
                    4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
  1. Asia Pacific Human Microbiome Market
    1. Asia PacificHuman Microbiome Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
        4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
      2. Japan Human Microbiome Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
          4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
        2. China Human Microbiome Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
            4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
          2. India Human Microbiome Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
              4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
            2. South Korea Human Microbiome Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
                4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
              2. Australia Human Microbiome Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                  3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
                  4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Human Microbiome Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                    3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
                    4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
  1. Latin AmericaHuman Microbiome Market
    1. Latin America Human Microbiome Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
        4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
      2. Brazil Human Microbiome Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
          4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
        2. Mexico Human Microbiome Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
            4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
          2. Argentina Human Microbiome Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
              4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
            2. Rest of Latin America Human Microbiome Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
                4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
  1. MEAHuman Microbiome Market
    1. MEA Human Microbiome Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
        4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
      2. GCC Human Microbiome Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
          4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
        2. South Africa Human Microbiome Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
            4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
          2. Rest of MEA Human Microbiome Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by Disease, 2021-2029 (USD Million)
              4. Market Size and Forecast by Research technology, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. ENTEROME Bioscience (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    2. Seres Therapeutics. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    3. 4D pharma (UK)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    4. Evelo Biosciences (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    5. OptiBiotix Health (UK)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    6. Synlogic (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    7. Second Genome (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    8. Vedanta Biosciences (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    9. Ferring Pharmaceuticals (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    10. ViThera Pharmaceuticals (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    11. ViThera Pharmaceuticals (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    12. BiomX (Israel)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    13. DuPont (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    14. Kaleido (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    15. YSOPIA Bioscience (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. ApplicationBenchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports